Delivery Order SPE2DB22D2007-SPE2DB25FJ5FG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order is valued at $13,647.57 with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and was competitively awarded through the federal procurement process. The place of...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $13,069.86 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia Clickject 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $21,369.30 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions such as rheumatoid arthritis. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a $76,256.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued on a...
- The Defense Logistics Agency awarded a $19,020.04 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, issued on September 29, 2025, with an ultimate completion date of September 30, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will take place at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,055.82 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $26,393.22 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a child order under a larger contract vehicle. The delivery is to be performed...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5FGDelivery Order
The Defense Logistics Agency awarded a $17,269.31 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded under open competition. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen's established role as a major federal pharmaceutical distributor and critical vendor for military and veteran healthcare systems demonstrates its capability to fulfill specialized pharmaceutical procurement needs across multiple therapeutic domains for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 9/23/25 |